U.S. Markets closed

How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines

ALLISON GATLIN
How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines

Alder could successfully compete with larger rivals Amgen, Lilly and Teva in preventing chronic migraines, analysts said Tuesday.